Datavault AI and Wellgistics Health Launch $4B DelivMeds AI Platform

In a transformative move poised to reshape healthcare delivery, Datavault AI (NASDAQ: DVLT) has announced a binding term sheet with Wellgistics Health (NASDAQ: WGRX) to create DelivMeds AI, a groundbreaking healthcare platform. This platform integrates AI-driven pharmacy optimization, blockchain-enabled smart contracts, biometric verification, and direct-to-consumer healthcare delivery through three concurrent transactions: an expanded PharmacyChain(TM) license, acquisition of QOLPOM intellectual property, and a controlling stake in Tollo Health. The combined transactions carry an expected approximate asset value of $4 billion, subject to an independent fairness opinion, and are designed to support a national rollout of data-driven healthcare delivery and patient engagement solutions.

Datavault AI, a leader in AI-driven data experiences and monetization in the Web 3.0 environment, brings its cloud-based platform expertise across Acoustic Sciences and Data Science divisions. The Acoustic Sciences division features WiSA(R), ADIO(R), and Sumerian(R) patented technologies for spatial and multichannel wireless sound transmission. The Data Science division leverages Web 3.0 and high-performance computing for data perception, valuation, and secure monetization. The platform serves industries including sports & entertainment, biotech, fintech, real estate, healthcare, and energy. The Information Data Exchange(R) enables Digital Twins and licensing of name, image, and likeness by anchoring to immutable metadata, fostering responsible AI.

This partnership signals a major leap in healthcare technology, combining Datavault AI's advanced data capabilities with Wellgistics Health's pharmaceutical infrastructure. The resulting DelivMeds AI platform aims to streamline prescription fulfillment, enhance patient verification through biometrics, and ensure secure transactions via blockchain. With an asset value of $4 billion, this initiative underscores the growing convergence of AI, blockchain, and healthcare—promising to improve accessibility, efficiency, and trust in medical services. Investors and industry watchers are keenly observing how this collaboration will set new standards for patient-centric care.